At Verastem Oncology, we're advancing innovation and addressing the urgent needs of patients living with cancers driven by RAS/MAPK pathway mutations, a key driver of tumor growth and treatment resistance. The FDA approval of AVMAPKI FAKZYNJA CO-PACK delivered the first therapy specifically for women living with recurrent KRAS-mutated low-grade serous ovarian cancer (LGSOC), a rare cancer with significant unmet need. We’ve successfully launched this innovative combination therapy in the U.S. and are exploring regulatory pathways for Europe and Japan. We are continuing to advance our pipeline of drugs that we believe will help block cancer cell survival, inhibit tumor growth, and overcome treatment resistance. With clinical trials underway, we have an exciting opportunity to shape the future of cancer care and make a meaningful impact on the lives of patients. Summary: Assists Regulatory Leadership with the development and implementation of Regulatory strategy for timely development of investigational products and guide and assist in preparation of domestic and international registration dossiers. Interface with program and cross-functional teams to provide Verastem Regulatory input into development plans, provide solutions to development and regulatory barriers, and identify and manage potential risks. Act as primary company liaison to FDA and partner with CRO Regulatory lead supporting OUS development. In addition, assess and inform Management of new Regulatory activities that may impact the Corporation’s short and long-term plans. The Senior Director, Regulatory Affairs has foresight, is action oriented, a problem-solver, is a good communicator, and works well with internal cross-functional and external project teams.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level